SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-019363
Filing Date
2019-10-01
Accepted
2019-10-01 08:15:32
Documents
12
Period of Report
2019-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092519_nektartherap.htm   iXBRL 8-K 29737
  Complete submission text file 0001213900-19-019363.txt   203398

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20190925.xsd EX-101.SCH 3170
3 XBRL LABEL FILE nktr-20190925_lab.xml EX-101.LAB 34581
4 XBRL PRESENTATION FILE nktr-20190925_pre.xml EX-101.PRE 22696
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k092519_nektartherap_htm.xml XML 3497
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 191127592
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences